From the Department of Psychiatry and the McGill University Health Centre, McGill University, Montréal, Que.
J Psychiatry Neurosci. 2024 Sep 19;49(5):E301-E318. doi: 10.1503/jpn.240037. Print 2024 Sep-Oct.
For 3000 years, psychedelics have been used in religious contexts to enhance spiritual thinking, well-being, and a sense of community. In the last few years, a renaissance in the use of psychedelic drugs for mental disorders has occurred in Western society; consequently, a pressing scientific need to elucidate the intricate mechanisms underlying their actions has arisen. Psychedelics mainly bind to serotonin (5-HT) receptors, particularly 5-HT receptors, but may also bind to other receptors. Unlike conventional psychotropic drugs used in psychiatry, psychedelics introduce a distinctive complexity. They not only engage in receptor activation, but also exert influence over specific neural circuits, thereby facilitating transformative cognitive experiences and fostering what many have identified as a spiritual contemplation or mystical experience. This comprehensive review describes clinical studies that have examined the propensity of psychedelics to enhance spiritual, mystical, and transcendent cognitive states. This multifaceted nature, encompassing diverse components and paradigms, necessitates careful consideration during the investigation of psychedelic mechanisms of action to avoid oversimplification. The present review endeavours to elucidate the mechanisms underlying the actions of 2 principal psychedelic substances, psilocybin and lysergic acid diethylamide (LSD), with a focus on monoamine and glutamate receptor mechanisms; molecular aspects, such as neuroplasticity and epigenetics; as well as the impact of psychedelics on brain circuits, including the default mode network and the cortico-striato-thalamo-cortical network. Given their distinctive and intricate mechanisms of action, psychedelics necessitate a novel conceptual framework in psychiatry, offering insight into the treatment of mental health disorders and facilitating the integration of the realms of brain, mind, and spirituality.
三千年来,迷幻剂一直被用于宗教领域,以增强精神思维、幸福感和社区意识。在过去的几年中,迷幻药物在西方社会中治疗精神障碍的应用出现了复兴;因此,迫切需要阐明其作用的复杂机制。迷幻剂主要与血清素(5-HT)受体结合,特别是 5-HT2A 受体,但也可能与其他受体结合。与精神科中使用的传统精神药物不同,迷幻剂引入了一种独特的复杂性。它们不仅参与受体激活,而且对特定的神经回路施加影响,从而促进变革性的认知体验,并促进许多人所识别的精神沉思或神秘体验。本综述描述了检查迷幻剂增强精神、神秘和超越认知状态倾向的临床研究。这种多方面的性质,包含不同的成分和范式,在研究迷幻剂作用机制时需要仔细考虑,以避免过度简化。本综述旨在阐明 2 种主要迷幻剂,即裸盖菇素和麦角酸二乙基酰胺(LSD)的作用机制,重点关注单胺和谷氨酸受体机制;分子方面,如神经可塑性和表观遗传学;以及迷幻剂对大脑回路的影响,包括默认模式网络和皮质-纹状体-丘脑-皮质网络。鉴于它们独特而复杂的作用机制,迷幻剂在精神病学中需要一个新的概念框架,为精神健康障碍的治疗提供了深入的了解,并促进了大脑、思维和精神领域的整合。